Sign in

CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
202726770
Phone
862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 4 Shares withheld for taxes Chief Medical Officer gave up 2,183 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 7,655 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,183 shares (to pay taxes)
  11. 4 Shares withheld for taxes President and CEO gave up 2,355 shares (to pay taxes)
  12. 4 Option exercise Director acquired 70 shares (option exercise)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)
  16. SC 13G Stake Amended Statement of Ownership
  17. 8-K Event Agreement ended
  18. 4 Option exercise Director acquired 139 shares (option exercise)
  19. 8-K Event Executive or director change · Regulation FD disclosure
  20. 4 Shares withheld for taxes President and CEO gave up 3,007 shares (to pay taxes)

Page 17 of 74 · 1,467 filings